NEUROTOXIC EFFECTS OF DRUGS ON SEROTONERGIC NEURONS
NEUROTOXIC EFFECTS OF DRUGS ON SEROTONERGIC NEURONS
批准号:
3210056
负责人:
MARK E MOLLIVER
金额:
$18.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-07-01 至 1995-06-30
关键词:
amphetamines autoradiography axon axon reaction brain mapping central nervous system dorsal raphe nucleus drug adverse effect drug metabolism embryo /fetus drug adverse effect enkephalins fluorescent dye /probe image processing immunocytochemistry laboratory rat myenteric plexus nervous system regeneration neural degeneration neuroanatomy neurogenesis neuronal guidance neurons neuropharmacology neurotoxins newborn animals prosencephalon psychotropic drugs serotonin tissue /cell culture
中文摘要
这一建议的目的是扩大我们正在进行的研究,
描述精神药物对多巴胺能神经元的神经毒性
神经元这些研究将主要采用解剖学方法,
描述神经元对药物诱导损伤的反应,
受损的神经元隔室,并将解剖学和
毒性的生化参数。这些实验应该确定
改变情绪的药物作用的部位,阐明药物的作用机制,
毒性,并评估研究药物神经毒性作用的标准。一
中心问题是评估神经毒性药物的结构证据
影响,以便为神经元损伤提供明确的证据,
确定损坏程度。目标是:一。进一步表征
3,4-亚甲二氧基-
安非他明(MDA)和相关安非他明衍生物:A.识别
完整的中缝轴突近端段,并测试假设,
退化仅限于轴突终端使用顺行轴突
运输; B.确定中缝细胞体对损伤的反应,
高分辨率光学和电子显微镜; C.分析5-HT
MDA处理后的神经再支配,并确定发芽的性质
5-HT轴突。R.表征神经毒性药物与5-HT的结合
摄取载体,并确定不同的摄取位点是否与
有两类5-羟色胺轴突,它们对这些神经元的敏感性不同,
毒品三.分析解剖与生化的相关性
相同动物的神经毒性参数。四.药物的影响
对肌间神经丛中5-HT神经元的影响将被研究,以确定
它们是否表现出与大脑类似的毒性作用。五.产前
将采用安非他明衍生物和脑啡肽的给药
研究它们对血清素神经元发育的影响,
对围产期前脑发育的继发性影响。的
拟议的研究应提供关于
药物诱导的神经毒性、再生潜力和药物
怀孕期间的影响。这些研究还应提供新的工具,
适用于人类和其他灵长类动物,用于评估
滥用药物。
英文摘要
The objective of this proposal, which extends our ongoing studies, is to
characterize the neurotoxicity of psychotropic drugs upon serotonergic
neurons. These studies will employ primarily anatomic methods to
characterize the response of neurons to drug-induced injury, to identify
the neuronal compartment that is damaged, and to correlate anatomic and
biochemical parameters of toxicity. These experiments should identify the
sites at which mood-altering drugs act, clarify the mechanisms of drug
toxicity, and evaluate criteria to study the neurotoxic effects of drugs. A
central issue is to evaluate structural evidence for neurotoxic drug
effects in order to provide definitive evidence for neuronal injury and to
determine the extent of damage. The aims are: I. Further characterize the
structural damage to serotonergic neurons produced by 3,4-methylenedioxy-
amphetamine (MDA) and related amphetamine derivatives: A. identify the
intact proximal segment of raphe axons and test the hypothesis that
degeneration is restricted to axon terminals using anterograde axonal
transport; B. determine the response of raphe cell bodies to injury using
high resolution light and electron microscopy; C. analyze 5-HT
reinnervation after MDA treatment and determine the properties of sprouting
5-HT axons. R. Characterize the binding of neurotoxic drugs to the 5-HT
uptake carrier, and determine whether different uptake sites are associated
with two classes of 5-HT axons that are differentially vulnerable to these
drugs. III. Analyze the correlation between anatomic and biochemical
parameters of neurotoxicity in the same animals. IV. The effects of drugs
on 5-HT neurons in the myenteric plexus will be studied to determine
whether they show toxic effects similar to those in the brain. V. Prenatal
administration of amphetamine derivatives and enkephalins will be employed
to study their effects on serotonin neuron development and possible
secondary effects on forebrain development in the perinatal period. The
proposed studies should provide new information regarding the mechanisms of
drug-induced neurotoxicity, the potential for regeneration, and drug
effects during pregnancy. These studies should also provide new tools,
applicable to man and other primates, for assessing the neurotoxicity of
drugs of abuse.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DRUG ADDICTION: DUAL 5-HT INNERVATION OF LIMBIC SYSTEM
-
批准号:6603955
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2001
-
负责人:MARK E MOLLIVER
-
依托单位:
DRUG ADDICTION: DUAL 5-HT INNERVATION OF LIMBIC SYSTEM
-
批准号:6515824
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2001
-
负责人:MARK E MOLLIVER
-
依托单位:
DRUG ADDICTION: DUAL 5-HT INNERVATION OF LIMBIC SYSTEM
-
批准号:6404210
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2001
-
负责人:MARK E MOLLIVER
-
依托单位:
MECHANISM OF IBOGAINE INDUCED PURKINJE CELL DEGENERATION
-
批准号:2121349
-
项目类别:
-
资助金额:$30.72万
-
财政年份:1994
-
负责人:MARK E MOLLIVER
-
依托单位:
MECHANISM OF IBOGAINE INDUCED PURKINJE CELL DEGENERATION
-
批准号:2121350
-
项目类别:
-
资助金额:$31.13万
-
财政年份:1994
-
负责人:MARK E MOLLIVER
-
依托单位:
MECHANISM OF IBOGAINE INDUCED PURKINJE CELL DEGENERATION
-
批准号:2733535
-
项目类别:
-
资助金额:$35.02万
-
财政年份:1994
-
负责人:MARK E MOLLIVER
-
依托单位:
MECHANISM OF IBOGAINE INDUCED PURKINJE CELL DEGENERATION
-
批准号:2121351
-
项目类别:
-
资助金额:$32.38万
-
财政年份:1994
-
负责人:MARK E MOLLIVER
-
依托单位:
MECHANISM OF IBOGAINE INDUCED PURKINJE CELL DEGENERATION
-
批准号:2443470
-
项目类别:
-
资助金额:$33.67万
-
财政年份:1994
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXICITY SCREENING
-
批准号:2306318
-
项目类别:
-
资助金额:$46.54万
-
财政年份:1993
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXICITY SCREENING
-
批准号:2306320
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1993
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXICITY SCREENING
-
批准号:2625795
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1993
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXICITY SCREENING
-
批准号:2306319
-
项目类别:
-
资助金额:$65.62万
-
财政年份:1993
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXICITY SCREENING
-
批准号:2306317
-
项目类别:
-
资助金额:$80.7万
-
财政年份:1993
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXICITY OF HALLUCINOGENIC SUBSTITUTED AMPHETAMINES
-
批准号:3210058
-
项目类别:
-
资助金额:$16.99万
-
财政年份:1987
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXICITY OF HALLUCINOGENIC SUBSTITUTED AMPHETAMINES
-
批准号:3210057
-
项目类别:
-
资助金额:$14.77万
-
财政年份:1987
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXIC EFFECTS OF DRUGS ON SEROTONERGIC NEURONS
-
批准号:3210059
-
项目类别:
-
资助金额:$20.65万
-
财政年份:1987
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXIC EFFECTS OF DRUGS ON SEROTONERGIC NEURONS
-
批准号:2117193
-
项目类别:
-
资助金额:$22.83万
-
财政年份:1987
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXIC EFFECTS OF DRUGS ON SEROTONERGIC NEURONS
-
批准号:3210060
-
项目类别:
-
资助金额:$21.24万
-
财政年份:1987
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXIC EFFECTS OF DRUGS ON SEROTONERGIC NEURONS
-
批准号:3210061
-
项目类别:
-
资助金额:$20.92万
-
财政年份:1987
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXICITY OF HALLUCINOGENIC SUBSTITUTED AMPHETAMINES
-
批准号:3210055
-
项目类别:
-
资助金额:$14.67万
-
财政年份:1987
-
负责人:MARK E MOLLIVER
-
依托单位:
海外基金